Article
Development of a high-throughput antiviral assay for screening inhibitors of chikungunya virus and generation of drug-resistant mutations in cultured cells.
Methods in molecular biology (Clifton, N.J.) - 1 Jan 2013
Gong Edwin Yunhao, Bonfanti Jean-François, Ivens Tania, Van der Auwera Marijke, Van Kerckhove Barbara, Kraus Guenter
Abstract excerpt
Chikungunya virus (CHIKV) is a mosquito-borne Alphavirus that has already infected millions of people in recent large-scale epidemics in Africa, the islands of the Indian Ocean, South and Southeast Asia, and northern Italy. The infection is still ongoing in many countries, such as India. Although the fatal rate is approximately 0.1% in the La Réunion outbreak, it causes painful arthritis-like symptoms that can...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
